The Thom Lab, an integrated genomics and cell biology lab, aims to define novel factors that regulate blood cell development and function in order to augment in vitro blood cell production.
The Lefebvre Lab advances the understanding of skeletal and neurodevelopmental syndromes. To this end, the team is decrypting mechanisms controlling the identity and activities of stem cells and differentiated cells governing these processes.
Developing a deeper understanding of diseases that cause thoracic insufficiency syndrome (TIS) and pioneering new devices to provide the best care in the world for patients with TIS.
Combining our proven clinical expertise in hemophilia gene therapy and care of bleeding disorders with our research expertise to solidify Children’s Hospital of Philadelphia as the premier center for the therapeutic development and advanced clinical care of inherited bleeding disorders.
Study instruments and tools must be provided at the time of protocol submission. This page provides a list of instruments the IRB recognizes as validated, which therefore do not have to be attached to a submission for IRB review.
